Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats

Diabetes/Metabolism Research and Reviews

Volumn 24, Issue 4, 2008, Pages 331-338

  Kamikawa, Akihiro ^a   Ishii, Tatsuya ^a   Shimada, Kohei ^a   Makondo, Kennedy ^a   Inanami, Osamu ^a   Sakane, Naoki ^b   Yoshida, Toshihide ^c   Saito, Masayuki ^a,d   Kimura, Kazuhiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d TENSHI COLLEGE   (Japan)

Author keywords

C peptide; eNOS; Insulin; Kidney; NO; PKC

Indexed keywords

C PEPTIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HUMAN C PEPTIDE; HUMAN INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFICACY; ENDOTHELIUM CELL; GLOMERULUS; GLUCOSE BLOOD LEVEL; HISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY PARENCHYMA; LUNG PARENCHYMA; MALE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; STREPTOZOCIN DIABETES; WEIGHT REDUCTION;

ANIMALS; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; ENDOTHELIAL CELLS; GLOMERULAR FILTRATION RATE; KIDNEY; KIDNEY GLOMERULUS; KINETICS; MALE; NITRIC OXIDE SYNTHASE; PROINSULIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 44949174161     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.810     Document Type: Article

References (33)

1. Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC. Structural-functional relationship in diabetic nephropathy. J Clin Invest 1984; 74: 1143-1155.
2. Krolewski A, Warram J, Christlieb A, Busick E, Kahn C. The changing natural history of nephropathy in type I diabetes. Am J Med 1985; 78: 785-794.
3. Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory: A paradigm shift in nephrology. Kidney Int 1996; 49: 1774-1777.
4. Bank N, Aynedjian HS. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 1993; 43: 1306-1312.
5. Komers R, Allen TJ, Cooper ME. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 1994; 43: 1190-1197.
6. Sugimoto H, Shikata K, Matsuda M, et al. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia 1998; 41: 1426-1434.
7. Wahren J. C-peptide: New findings and therapeutic implications in diabetes. Clin Physiol Funct Imaging 2004; 24: 180-189.
8. Marques RG, Fontaine MJ, Rogers J. C-peptide. Much more than a byproduct of insulin biosynthesis. Pancreas 2004; 29: 231-238.
9. Johansson BL, Sjoberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 1992; 35: 121-128.
10. Johansson BL, Kernell A, Sjoberg S, Wahren J. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 1993; 77: 976-981.
11. Sjoquist M, Huang W, Johansson BL. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 1998; 54: 758-764.
12. Huang D-Y, Richter K, Breidenbach A, Vallon V. Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study. Naunyn-Schmiedebergs Arch Pharmacol 2002; 365: 67-73.
13. Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Sjoquist M. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int 2001; 60: 1258-1265.
14. Samnegard B, Jacobson SH, Jaremko G, et al. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol Dial Transplant 2005; 20: 532-538.
15. Sima AAF, Kamiya H, Li ZG. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur J Pharmacol 2004; 490: 187-197.
16. Forst T, Kunt T, Pohlmann T, et al. Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. J Clin Invest 1998; 101: 2036-2041.
17. Ido Y, Vindigni A, Chang K, et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 1997; 277: 563-566.
18. Cotter MA, Ekberg K, Wahren J, Cameron NE. Effects of proinsulin C-peptide in experimental diabetic neuropathy. Diabetes 2003; 52: 1812-1817.
19. +-ATPase activity in diabetes mellitus type I. Clin Sci 2000; 98: 283-290.
20. Johansson BL, Wahren J, Pernow J. C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism. Am J Physiol Endocrinol Metab 2003; 285: E864-E870.
21. Scalia R, Coyle KM, Levine BJ, Booth G, Leffer AM. C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction. FASEB J 2000; 14: 2357-2364.
22. Wallerath T, Kunt T, Forst T, et al. Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide. Nitric Oxide 2003 9: 95-102.
23. Kitamura T, Kimura K, Makondo K, et al. Proinsulin C-peptide increases nitric oxide production through mitogen-activated protein kinase-dependent transcriptional enhancement of endothelial nitric oxide synthase in rat aortic endothelial cells. Diabetologia 2003; 46: 1698-1705.
24. Rebsomen L, Pitel S, Boubred F, et al. C-peptide replacement improves weight gain and renal function in diabetic rats. Diabetes Metab 2006; 32: 223-228.
25. Gotoh M, Li C, Yatoh M, Okabayashi N, Habu S, Hirooka Y. Hypothalamic monoamine metabolism is different between the diabetic (Goto-Kakizuka) rats and streptozotocin-induced diabetic rats. Brain Res 2006; 1073-1074: 497-503.
26. Weibel ER. Stereological methods. Practical Methods for Biological Morphometry. Academic Press: London, 1979; 51-57.
27. Davis ME, Cai H, Drummond GR, Harrison DG. Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways. Circ Res 2001; 89: 1073-1080.
28. Nordquist L, Lai E-Y, Sjoquist M, Persson AEG. Proinsulin C-peptide constricts afferent glomerular arterioles in diabetic mice. A potential reno-protective mechanism of action. Diabetologia 2006; 49(Suppl. 1): 105-106.
29. Fajardo LF. The complexity of endothelial cells. Am J Clin Pathol 1989; 92: 241-250.
30. Wang Q, Pfeiffer GR II, Stevens T, Doerschuk CM. Lung microvascular and arterial endothelial cells differ in their responses to intercellular adhesion molecule-1 ligation. Am J Respir Crit Care Med 2002; 166: 872-877.
31. Kolonin M, Saha PK, Chan L, Pasqualini R, Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat Med 2004; 10: 625-632.
32. Thallas-Bonke V, Lindschau C, Rizkalla B, et al. Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-117 via a protein kinase C-α-dependent pathway. Diabetes 2004; 53: 2921-2930.
33. Menne J, Park J-K, Boehne M, et al. Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-α-deficient diabetic mice. Diabetes 2004; 53: 2101-2109.